Keyphrases
Renal Transplant Recipients
100%
Cardiovascular Events
100%
Statin Use
100%
Cyclosporine
71%
Statins
57%
Subgroup Analysis
28%
Cardiovascular Mortality
28%
Adjusted Model
28%
Cardiovascular Endpoints
28%
Conclusive Evidence
14%
Survival Analysis
14%
Correlation Coefficient
14%
Simultaneous Use
14%
Clinical Practice Guidelines
14%
Cardiovascular Outcomes
14%
Propensity Score
14%
Cox Regression
14%
Trough Level
14%
Pharmacological Interactions
14%
Specific Events
14%
Cardiovascular Risk Reduction
14%
Nursing and Health Professions
Kidney Graft
100%
Statin (Protein)
100%
Ciclosporin
71%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
57%
Practice Guideline
14%
Cardiovascular Risk
14%
Population
14%
Proportional Hazards Model
14%
Correlation Coefficient
14%
Cardiovascular Mortality
14%
Propensity Score
14%
Survival Analysis
14%
Immunosuppressive Agent
14%
Pharmacology, Toxicology and Pharmaceutical Science
Statin (Protein)
100%
Ciclosporin
83%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
66%
Immunosuppressive Agent
16%
Cardiovascular Risk
16%
Cardiovascular Mortality
16%
Trough Level
16%